The review assessed the efficacy and safety of herbal therapies and vitamin and mineral supplements for glucose control in patients with diabetes. The authors concluded that there is insufficient evidence to draw definitive conclusions about the efficacy of individual herbs and supplements. The authors' tentative conclusions are in line with the limitations of the current trials.
Adverse effects with a TCM herb combination (1 patient had diarrhoea, 1 patient had dry mouth) and a Native American herb combination (1 patient had minor gastrointestinal discomfort) were reported.
Vitamin and mineral supplements for glycaemic control.
Alpha-lipoic acid, chromium, magnesium and vitamin E supplements were found to significantly positively change at least one outcome measure. Carnitine, chromium, magnesium, vanadium and vitamin E supplements were found to significantly positively change more than 50% of the outcomes measured.
Adverse effects with magnesium supplements (1 patient had exanthema and 1 patient had gastrointestinal pain) and vanadium supplements (5 of 6 patients had transient gastrointestinal discomfort in one study; all 7 patients in another study had transient gastrointestinal discomfort) were reported.
Authors' conclusions
There is insufficient evidence to draw definitive conclusions about the efficacy of individual herbs and supplements for diabetes. However, most of the herbs and supplements reviewed appeared to be generally safe. The best evidence for efficacy from adequately designed RCTs is available for Coccinia indica and American ginseng. Other supplements with positive preliminary results include Gymnema sylvestre, Aloe vera, vanadium, Momordica charantia and Opuntia streptacantha (nopal). Further evaluation of several herbs, vitamins and mineral supplements for glucose control in diabetes is warranted.
CRD commentary
The review question was clear in terms of the participants, interventions and outcomes of interest. However, the authors did not state which study designs were eligible for inclusion prior to conducting their search for literature. Their review focused on the controlled clinical trials that their search identified. Three relevant electronic databases were searched and the search terms and dates were reported. This search was supplemented by handsearching references and contacting experts in the field in an attempt to identify additional studies. However, no additional searches for unpublished literature were undertaken and only English language publications were eligible for inclusion. The possibility of publication bias and language bias cannot, therefore, be excluded. Two reviewers applied a validated scale for assessing the quality of RCTs; the authors did not state how non-randomised controlled trials were evaluated for quality. The methods used to select the studies for the review and to extract the data from the primary studies were not described; hence, the possibility of reviewer bias and error cannot be assessed.
Adequate details of the individual studies were tabulated and discussed further in the text. The narrative synthesis was appropriate given the heterogeneity between the trials and the small number of studies evaluating each supplement. The authors' tentative conclusions are supported by the results of their review.
Implications of the review for practice and research
Practice: The authors stated that there is insufficient evidence to actively recommend or discourage the use of any particular supplement for glucose control in diabetes, although most of the supplements reviewed appeared to be generally safe. Clinicians should keep an open mind when advising patients on the use of these supplements; they should be guided by the patients' preferences, needs and values, in addition to their own clinical judgement.
Research: The authors stated that further evaluation of herbs, vitamins and mineral supplements for glucose control in diabetes is required. Future research should benefit from defining populations more precisely with regard to disease classification and severity, optimal adjunctive interventions and nutrient deficiencies. Mechanisms of action need elucidation so that the applicability to type 1 or type 2 diabetes can be clarified.
